Non Alcoholic Fatty Liver Disease Treatment Market

Fatty liver disease refers to the accumulation of fat (triglycerides,) in the liver. The liver cell contains fats, but the accumulation of excess fat can be a cause of concern and can lead to liver inflammation known as steatohepatitis. The fatty liver can be caused by alcohol as well as can be non-alcohol. Steatohepatitis can cause liver cirrhosis (fibrosis, scarring, and hardening of the liver). The cause of non-alcoholic fatty liver disease (NAFLD) is unknown. The nonalcoholic fatty liver disease (NAFLD) is one of the most common diseases in the United States. The prevalence of nonalcoholic fatty liver disease (NAFLD) is rising due to rise in prevalence of diabetes and obesity. According to National Health and Nutrition Examination survey, about 20-30% of the general population in the western world suffer from nonalcoholic fatty liver disease (NAFLD). The common symptoms include fatigue, weakness, weight loss and others. The diagnosis of NAFLD requires the combination of different tests such as blood test, ultrasound, CT scan, MRI scan, and liver biopsy. The two types of Nonalcoholic fatty liver disease (NAFLD) includes simple fatty liver and Nonalcoholic Steatohepatitis (NASH). The simple fatty liver is a type of nonalcoholic fatty liver (NAFL), in which fat is deposited, but no inflammation or liver damage is observed. NASH is the inflammation of the liver due to excess fat deposit and can lead to liver damage and disease.
Non Alcoholic Fatty Liver Disease Treatment Market aims to provide a comprehensive presentation of the global market for Non Alcoholic Fatty Liver Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non Alcoholic Fatty Liver Disease Treatment. Non Alcoholic Fatty Liver Disease Treatment Market contains market size and forecasts of Non Alcoholic Fatty Liver Disease Treatment in global, including the following market information:
Global Non Alcoholic Fatty Liver Disease Treatment Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Non Alcoholic Fatty Liver Disease Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is estimated to lead the global nonalcoholic fatty liver disease treatment market due to increase in prevalence of diabetes and cardiovascular diseases in United States. Large number of manufacturers exist in the market, with large number of customer base. Asia Pacific market is also projected to experience high growth in the near future owing to factors such as, increase in healthcare expenditure, rising standard of living, lifestyle changes- attributed to better healthcare and awareness of the cost-effective treatment process with government grants and funding for acceleration in research and development activities.
We surveyed the Non Alcoholic Fatty Liver Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non Alcoholic Fatty Liver Disease Treatment Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Non Alcoholic Fatty Liver Disease Treatment Market Segment Percentages, by Type, 2022 (%)
Antioxidants
Thiazolidinedione
Biguanides
Lipid lowering Agents
FXR Receptor Agonist
Others
Global Non Alcoholic Fatty Liver Disease Treatment Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Non Alcoholic Fatty Liver Disease Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Online Pharmacy
Others
Global Non Alcoholic Fatty Liver Disease Treatment Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Non Alcoholic Fatty Liver Disease Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non Alcoholic Fatty Liver Disease Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Non Alcoholic Fatty Liver Disease Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Daewoong
Cardax
Merck
Novartis
Gilead Sciences
AstraZeneca
Limerick BioPharma
GW Pharmaceuticals
Allergan
Takeda Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non Alcoholic Fatty Liver Disease Treatment, market overview.
Chapter 2: Global Non Alcoholic Fatty Liver Disease Treatment market size in revenue.
Chapter 3: Detailed analysis of Non Alcoholic Fatty Liver Disease Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non Alcoholic Fatty Liver Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.